Literature DB >> 29573575

Heart rate response and functional capacity in patients with chronic heart failure with preserved ejection fraction.

Eloy Domínguez1, Patricia Palau1, Eduardo Núñez2, José María Ramón2, Laura López3, Joana Melero1, Alejandro Bellver1, Enrique Santas2, Francisco J Chorro2, Julio Núñez2.   

Abstract

AIMS: The mechanisms of exercise intolerance in heart failure with preserved ejection fraction (HFpEF) are not yet elucidated. Chronotropic incompetence has emerged as a potential mechanism. We aimed to evaluate whether heart rate (HR) response to exercise is associated to functional capacity in patients with symptomatic HFpEF. METHODS AND
RESULTS: We prospectively studied 74 HFpEF patients [35.1% New York Heart Association Class III, 53% female, age (mean ± standard deviation) 72.5 ± 9.1 years, and 59.5% atrial fibrillation]. Functional performance was assessed by peak oxygen consumption (peak VO2 ). The mean (standard deviation) peak VO2 was 10 ± 2.8 mL/min/kg. The following chronotropic parameters were calculated: Delta-HR (HR at peak exercise - HR at rest), chronotropic index (CI) = (HR at peak exercise - resting HR)/[(220 - age) - resting HR], and CI according to the equation developed by Keteyian et al. (CIK) (HR at peak exercise - HR at rest)/[119 + (HR at rest/2) - (age/2) - 5 - HR at rest]. In a bivariate setting, peak VO2 was positively and significantly correlated with Delta-HR (r = 0.35, P = 0.003), CI (r = 0.27, P = 0.022), CIK (r = 0.28, P = 0.018), and borderline with HR at peak exercise (r = 0.22, P = 0.055). In a multivariable linear regression analysis that included clinical, analytical, echocardiographic, and functional capacity covariates, the chronotropic parameters were positively associated with peak VO2 . We found a linear relationship between Delta-HR and peak VO2 (β coefficient of 0.03; 95% confidence interval: 0.004-0.05; P = 0.030); conversely, the association among CIs and peak VO2 was exponentially shaped.
CONCLUSIONS: In patients with chronic HFpEF, the HR response to exercise was positively associated to patient's functional capacity.
© 2018 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.

Entities:  

Keywords:  Chronotropic response; Functional capacity; Heart failure with preserved ejection fraction

Mesh:

Year:  2018        PMID: 29573575      PMCID: PMC6073018          DOI: 10.1002/ehf2.12281

Source DB:  PubMed          Journal:  ESC Heart Fail        ISSN: 2055-5822


  39 in total

Review 1.  Mechanisms of exercise intolerance in heart failure with preserved ejection fraction.

Authors:  Barry A Borlaug
Journal:  Circ J       Date:  2013-12-03       Impact factor: 2.993

2.  Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction.

Authors:  Barry A Borlaug; Thomas P Olson; Carolyn S P Lam; Kelly S Flood; Amir Lerman; Bruce D Johnson; Margaret M Redfield
Journal:  J Am Coll Cardiol       Date:  2010-09-07       Impact factor: 24.094

Review 3.  Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium.

Authors:  M R Bristow; R E Hershberger; J D Port; E M Gilbert; A Sandoval; R Rasmussen; A E Cates; A M Feldman
Journal:  Circulation       Date:  1990-08       Impact factor: 29.690

4.  Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction.

Authors:  Barry A Borlaug; Vojtech Melenovsky; Stuart D Russell; Kristy Kessler; Karel Pacak; Lewis C Becker; David A Kass
Journal:  Circulation       Date:  2006-11-06       Impact factor: 29.690

5.  Impaired chronotropic response to exercise in patients with congestive heart failure. Role of postsynaptic beta-adrenergic desensitization.

Authors:  W S Colucci; J P Ribeiro; M B Rocco; R J Quigg; M A Creager; J D Marsh; D F Gauthier; L H Hartley
Journal:  Circulation       Date:  1989-08       Impact factor: 29.690

6.  Impaired chronotropic response to exercise stress testing as a predictor of mortality.

Authors:  M S Lauer; G S Francis; P M Okin; F J Pashkow; C E Snader; T H Marwick
Journal:  JAMA       Date:  1999-02-10       Impact factor: 56.272

7.  Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry.

Authors:  Adrian F Hernandez; Bradley G Hammill; Christopher M O'Connor; Kevin A Schulman; Lesley H Curtis; Gregg C Fonarow
Journal:  J Am Coll Cardiol       Date:  2009-01-13       Impact factor: 24.094

Review 8.  Exercise testing for chronotropic assessment.

Authors:  B L Wilkoff; R E Miller
Journal:  Cardiol Clin       Date:  1992-11       Impact factor: 2.213

9.  Remodeling of sinus node function in patients with congestive heart failure: reduction in sinus node reserve.

Authors:  Prashanthan Sanders; Peter M Kistler; Joseph B Morton; Steven J Spence; Jonathan M Kalman
Journal:  Circulation       Date:  2004-08-09       Impact factor: 29.690

10.  Impaired heart rate recovery and chronotropic incompetence in patients with heart failure with preserved ejection fraction.

Authors:  Thanh Trung Phan; Ganesh Nallur Shivu; Khalid Abozguia; Chris Davies; Mohammad Nassimizadeh; Donie Jimenez; Rebekah Weaver; Ibrar Ahmed; Michael Frenneaux
Journal:  Circ Heart Fail       Date:  2009-11-16       Impact factor: 8.790

View more
  9 in total

1.  Heart rate response and functional capacity in patients with chronic heart failure with preserved ejection fraction.

Authors:  Eloy Domínguez; Patricia Palau; Eduardo Núñez; José María Ramón; Laura López; Joana Melero; Alejandro Bellver; Enrique Santas; Francisco J Chorro; Julio Núñez
Journal:  ESC Heart Fail       Date:  2018-03-24

Review 2.  Signaling cascades in the failing heart and emerging therapeutic strategies.

Authors:  Xin He; Tailai Du; Tianxin Long; Xinxue Liao; Yugang Dong; Zhan-Peng Huang
Journal:  Signal Transduct Target Ther       Date:  2022-04-23

Review 3.  Cellular and molecular pathobiology of heart failure with preserved ejection fraction.

Authors:  Sumita Mishra; David A Kass
Journal:  Nat Rev Cardiol       Date:  2021-01-11       Impact factor: 49.421

4.  Beta-blockers withdrawal in patients with heart failure with preserved ejection fraction and chronotropic incompetence: Effect on functional capacity rationale and study design of a prospective, randomized, controlled trial (The Preserve-HR trial).

Authors:  Patricia Palau; Julia Seller; Eloy Domínguez; Inés Gómez; José María Ramón; Clara Sastre; Rafael de la Espriella; Enrique Santas; Gema Miñana; Francisco J Chorro; José Ramón González-Juanatey; Julio Núñez
Journal:  Clin Cardiol       Date:  2020-02-19       Impact factor: 2.882

5.  Effects of αβ-Blocker Versus β1-Blocker Treatment on Heart Rate Response During Incremental Cardiopulmonary Exercise in Japanese Male Patients with Subacute Myocardial Infarction.

Authors:  Shinji Nemoto; Yusuke Kasahara; Kazuhiro P Izawa; Satoshi Watanabe; Kazuya Yoshizawa; Naoya Takeichi; Kentaro Kamiya; Norio Suzuki; Kazuto Omiya; Atsuhiko Matsunaga; Yoshihiro J Akashi
Journal:  Int J Environ Res Public Health       Date:  2019-08-08       Impact factor: 3.390

Review 6.  Highlights in heart failure.

Authors:  Daniela Tomasoni; Marianna Adamo; Carlo Mario Lombardi; Marco Metra
Journal:  ESC Heart Fail       Date:  2019-12

7.  Diastolic Filling Time, Chronotropic Response, and Exercise Capacity in Heart Failure and Preserved Ejection Fraction With Sinus Rhythm.

Authors:  Kazuki Kagami; Masaru Obokata; Tomonari Harada; Toshimitsu Kato; Naoki Wada; Takeshi Adachi; Hideki Ishii
Journal:  J Am Heart Assoc       Date:  2022-06-29       Impact factor: 6.106

Review 8.  Heart failure with preserved ejection fraction based on aging and comorbidities.

Authors:  Ying Lin; Shihui Fu; Yao Yao; Yulong Li; Yali Zhao; Leiming Luo
Journal:  J Transl Med       Date:  2021-07-06       Impact factor: 5.531

Review 9.  Skeletal muscle (dys)function in heart failure with preserved ejection fraction.

Authors:  Eng Leng Saw; Swetha Ramachandran; Maria Valero-Muñoz; Flora Sam
Journal:  Curr Opin Cardiol       Date:  2021-03-01       Impact factor: 2.108

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.